Comparative Effects of UE Aerobic and Resistance Training on Cardiorespiratory Fitness in Hypertensive Patients

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05936892
Collaborator
(none)
40
1
2
6.2
6.4

Study Details

Study Description

Brief Summary

simple random sampling into group A & group B to collect data. Group A will be given upper extremity aerobic training and group B will be given upper extremity resistance training. The study will be completed within the time duration of ten months. Primary Outcome measures of the research will be pain, range of motion, and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: upper extremity aerobic training
  • Other: upper extremity resistance training
N/A

Detailed Description

A randomized clinical trial will be conducted at Multan institute of cardiology, Multan. Non probability convenient sampling technique will be applied on--patients who will be allocated through simple random sampling into group A & group B to collect data. Group A will be given upper extremity aerobic training and group B will be given upper extremity resistance training. The study will be completed within the time duration of ten months. Primary Outcome measures of the research will be pain, range of motion, and quality of life. Data will be analyzed using SPSS software version 25. After assessing normality of data by Shapiro-wilk test, it will be decided either parametric or non-parametric test will be used within a group or between two groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparative Effects of UE Aerobic and Resistance Training on Cardiorespiratory Fitness in Hypertensive Patients
Actual Study Start Date :
May 15, 2023
Anticipated Primary Completion Date :
Sep 10, 2023
Anticipated Study Completion Date :
Nov 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: upper extremity aerobic training

upper extremity aerobic training

Other: upper extremity aerobic training
upper extremity aerobic training & baseline treatment will be given. Overall session time will be 40-45 minutes

Experimental: upper extremity resistance training

upper extremity resistance training

Other: upper extremity resistance training
upper extremity resistance training Overall session time will be 40-45 minutes

Outcome Measures

Primary Outcome Measures

  1. 6 MWT RESISTANCE TRAINING ON CARDIORESPIRATORY FITNESS IN HYPERTENSIVE PATIENTS [4 weeks]

    The 6MWT is a practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians. This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes (the 6MWD).The self-paced 6MWT assesses the submaximal level of functional capacity. (19) According to studies, the distance walked by a healthy subject on six-minute walk test ranges from 400 to 700m. Men ranged from 735m to 580m. Women ranged from 657m to 500m.

Secondary Outcome Measures

  1. Borg rating of perceived exertion (RPE) [4 weeks]

    Borg rating of perceived exertion (RPE) is an outcome measure scale used in knowing exercise intensity prescription. It is used in monitoring progress and mode of exercise in cardiac patients as well as in other patient populations undergoing rehabilitation and endurance training.Borg RPE scale was developed by Gunnar Borg for rating exertion and breathlessness during physical activity ; that is, how hard the activity is as shown by high heart and respiration rate , profuse perspiration and muscle exertion. RPE scale contains 10 points (20). 1 denotes very light activity 2-3 denotes light activity 4-6 denotes moderate activity 7-8 denotes vigorous activity 9 denotes very hard activity 10 denotes maximum effort activity training.

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age group of 35-65years

  • Both male and females

  • Patients with blood pressure >140/90mm Hg

Exclusion Criteria:
  • Regular engagement in physical exercise training in past 4 weeks

  • Patients with secondary hypertension

  • Patients using more than one hypertensive drugs

  • Recent myocardial infarction

  • Congestive heart failure

  • Uncontrolled cardiac arrythmia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Multan Institute of Cardiology, Multan Multān Punjab Pakistan

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Sidra Faisal, MS.CPPT, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05936892
Other Study ID Numbers:
  • REC/RCR & AHS/23/0309
First Posted:
Jul 10, 2023
Last Update Posted:
Jul 10, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University

Study Results

No Results Posted as of Jul 10, 2023